Home › Funds › Affinity Asset Advisors, LLC › PRLD
Affinity Asset Advisors, LLC position in PRLD
PRELUDE THERAPEUTICS INC · Health Care
Affinity Asset Advisors, LLC reported holding 2,600,000 shares of PRLD (PRELUDE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$10.2M, representing 0.47% of its reported portfolio and ranking #47 among its reported holdings. Affinity Asset Advisors, LLC first reported this position in Q3 2026.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Affinity Asset Advisors, LLC's PRLD position evolved
Affinity Asset Advisors, LLC first disclosed a stake in PRLD in Q3 2026 at 2,600,000 shares (US$10.2M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 2.60M | $10.17M | New |
About PRLD and 13F data
PRLD (PRELUDE THERAPEUTICS INC) is a Health Care company. 42 other funds we track also report a position in PRLD — the largest reported positions include BAKER BROS. ADVISORS LP (US$54.0M), RA CAPITAL MANAGEMENT, L.P. (US$34.5M), ORBIMED ADVISORS LLC (US$30.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PRLD
- BAKER BROS. ADVISORS LP 10.12M sh · $53.96M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 6.48M sh · $34.52M · Q2 2026
- ORBIMED ADVISORS LLC 5.68M sh · $30.28M · Q2 2026
- Soleus Capital Management, L.P. 3.38M sh · $18.01M · Q2 2026
- Kynam Capital Management, LP 2.42M sh · $12.87M · Q2 2026
- SPHERA FUNDS MANAGEMENT LTD. 1.02M sh · $5.44M · Q2 2026
More on Affinity Asset Advisors, LLC
FAQ
How long has Affinity Asset Advisors, LLC held PRLD?
Affinity Asset Advisors, LLC has disclosed PRLD holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Affinity Asset Advisors, LLC's current position in PRLD?
As of Q3 2026, Affinity Asset Advisors, LLC holds 2.60M shares of PRLD (PRELUDE THERAPEUTICS INC), valued at $10.17M, representing 0.47% of its reported portfolio and ranking #47.
Has Affinity Asset Advisors, LLC been buying or selling PRLD?
In the latest 13F filing (Q3 2026), Affinity Asset Advisors, LLC newly opened its position in PRLD.
Which other funds hold PRLD?
Other major institutional holders of PRLD include BAKER BROS. ADVISORS LP, RA CAPITAL MANAGEMENT, L.P., ORBIMED ADVISORS LLC, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.